• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

narcolepsy

Sunlight streaming through window in morning onto alarm clock
Biotech

The GLP-like race to keep us awake and make billions doing it

Experts told Fierce that orexin mimics have much broader potential than narcolepsy and could even become the “GLPs of neuroscience.”
Darren Incorvaia Aug 31, 2026 11:24am
Sleep disorder insomnia

Lilly pays $6.3B upfront for sleep disorder-focused Centessa

Mar 31, 2026 8:53am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Alkermes races to phase 3 after posting another narcolepsy win

Nov 12, 2025 9:30am
Takeda

Takeda drops AZ-partnered neurological program after ph. 2 fail

Oct 30, 2025 9:25am
Close up of horse legs and hooves running on sand track

Takeda, Alkermes lift lid on narcolepsy rivals as race heats up

Sep 8, 2025 6:47am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Chasing Takeda, Alkermes reports phase 2 narcolepsy win

Jul 21, 2025 8:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings